▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1156 by analyst upside · 2026-11-13
SMMT
Summit Therapeutics Inc.
Healthcare · Market Cap $12B · P/E 0x
ANALYST PRICE TARGET
+96.1%
implied upside to consensus target
Current Price $15.07
Consensus Target $29.56
Bull Target $42.28
Bear Target $11.74
Analysts Covering 13
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
8
Hold
5
Sell
0
52-Week Low $12.07
52-Week High $29.23
YTD Return -14.0%
FUNDAMENTALS
Market Cap $12B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.06
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $12.07
52-Week High $29.23
Current Price $15.07
Bear Target $11.74
Bull Target $42.28
● Now $15.07 ● Target $29.56
TRADING DATA
Avg Volume 6.3M
YTD Return -14.0%
Analyst Count 13
Consensus Buy
Upside to Target +96.1%
Last Updated 2026-11-13

ANALYST SUMMARY

Summit Therapeutics Inc. (SMMT) is currently trading at $15.07 with a Wall Street consensus price target of $29.56, implying potential upside of 96.1% over the next 12 months. 13 analysts currently cover SMMT, with a consensus rating of Buy - 64% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $42.28, while the most cautious has a target of $11.74.

SMMT operates in the Healthcare sector with a market capitalisation of $12B. The stock is down 14.0% year-to-date and is currently trading near the lower end of its 52-week range of $12.07 – $29.23.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

DVA +27.7%
DaVita Inc.
$11B · P/E 13.2x · Hold
GMED +29.2%
Globus Medical, Inc.
$10B · P/E 17.8x · Buy
FMS +6.8%
Fresenius Medical Care AG
$11B · P/E 12.5x · Hold
OSCR +15.8%
Oscar Health, Inc.
$10B · P/E 14.2x · Buy
UHS +0.7%
Universal Health Services, Inc.
$11B · P/E 8.1x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for SMMT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-10-01 Building track record
Citigroup - Reiterated
Buy → Buy 2026-09-29 Building track record
HC Wainwright & Co. reit
Neutral → Neutral 2026-09-23 31% win rate (48 calls)
Jefferies ↑ Upgrade
Hold → Buy 2026-09-09 50% win rate (6 calls)
HC Wainwright & Co. reit
Neutral → Neutral 2026-08-26 31% win rate (48 calls)
Bernstein ↑ Upgrade
Underperform → Market Perform 2026-08-25 Building track record
HC Wainwright & Co. reit
Neutral → Neutral 2026-08-18 31% win rate (48 calls)
Leerink Partners ↑ Upgrade
Underperform → Market Perform 2026-08-12 29% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
34
out of 100
Coverage depth
20/30
Consensus clarity
0/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →